Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 25, 2026
Coca-Cola Consolidated (COKE) Trading Near $192: Is a +30% Move to $250 Realistic?

Coca-Cola Consolidated (COKE) Trading Near $192: Is a +30% Move to $250 Realistic?

Key Takeaways

  • COKE shares recently traded near $192, leaving roughly a 30% gap to the widely discussed $250 price level.
  • $250 would mark a new all-time high, above the stock's previous record close around $219.65 set in March 2026.
  • The strongest bullish factors are resilient pricing power, aggressive share repurchases, and a proven multi-year earnings track record.
  • The biggest obstacles are a leveraged balance sheet, softer net income despite rising sales, and shifting consumer demand for healthier beverages.
  • Key technical levels include psychological support near $180 and major resistance at the prior all-time high near $220.
  • The key takeaway: $250 is achievable over a multi-quarter horizon, but it likely requires renewed earnings momentum and a break above the prior record high.

Why the $250 Level Stands Out

Coca-Cola Consolidated, Inc. (COKE) is the largest independent Coca-Cola bottler in the United States, manufacturing and distributing nonalcoholic beverages primarily for The Coca-Cola Company across 14 states and Washington, D.C. Unlike the brand-owning parent, COKE is a logistics- and execution-driven business, making its margins and pricing power central to the investment case.

The $250 stock price target is significant because it sits well above the company's all-time high near $219.65, a level reached in March 2026. Reaching $250 would therefore require COKE to first reclaim its record high and then extend into genuinely uncharted territory. For a stock that has compounded strongly over recent years — posting a five-year total return well in excess of the broader market — the round $250 figure has become a natural psychological milestone in investor discussion. I checked recent patterns here using Tickeron’s AI Pattern Search Engine to see how similar setups have played out historically.

COKE’s Current Market Position

Coca-Cola Consolidated trades as a mid-cap common stock with a market capitalization near $12.8 billion and a price-to-earnings (P/E) ratio in the mid-20s based on trailing earnings of roughly $7.67 per share. The stock's 52-week range spans from about $110.60 to $219.65, and its dividend yield is modest at roughly 0.5%.

Recent financial results have presented a mixed picture. Sales have continued to climb — full-year 2025 revenue reached approximately $7.23 billion — yet net income stepped down from prior-year levels, reflecting margin pressure, a product mix shift, and input-cost headwinds. Notably, diluted earnings per share still advanced in some periods because of a shrinking share count, the direct result of sustained buybacks.

Factors That Could Support a Move Higher

Several factors support the case that COKE could eventually trade toward $250. First, the company enjoys strong regional pricing power within its franchise territories, which helps protect revenue even when volume growth is tepid. Second, its distributed portfolio extends beyond Coca-Cola brands to include Monster Energy and Dr Pepper products, adding diversification across the energy and flavored-beverage categories.

Third, management has returned substantial capital to shareholders through buybacks, which have reduced the outstanding share count and mechanically lifted earnings per share. Finally, the company's scale and established distribution network create meaningful barriers to entry, supporting the durability of its cash generation over time. From what I see, the combination of pricing discipline and capital returns remains a core strength worth watching closely.

Headwinds That Could Slow Progress

The path to $250 is not without friction. COKE carries a leveraged balance sheet with meaningful debt and, at times, negative shareholder equity driven by its repurchase activity. Rising interest costs and any slowdown in consumer beverage demand could pressure margins and weigh on sentiment.

Longer term, shifting consumer preferences toward healthier, lower-sugar options, potential regulatory action on sugar, and competition from rivals such as PepsiCo and Keurig Dr Pepper remain structural risks. Because the company is a bottler rather than a brand owner, its profitability is especially sensitive to operating efficiency and supply-chain management.

Analyst Views and Valuation Range

Wall Street coverage of COKE is notably thin, which makes a precise consensus difficult to establish. Independent valuations span a wide range, with some community-based fair-value estimates extending from the high $120s to above $250 per share, while more aggressive quantitative targets run far higher. The dispersion itself underscores the uncertainty surrounding the stock's forward path. The $250 objective sits within the upper end of several base-case and fair-value scenarios, suggesting it is ambitious but not out of reach relative to the broader range of published estimates.

Important Technical Levels

From a technical analysis perspective, the most important level is the prior all-time high near $220. That zone now acts as a major resistance level, and a decisive close above it would likely be required before a sustained push toward $250 can gain momentum. On the downside, the $180 area has functioned as a psychological support level, with the stock having rebounded from that region in recent months.

Monitoring Real-Time Signals

To stay on top of real-time signals for stocks like COKE, I often turn to Tickeron's AI Daily Buy/Sell Signals. It provides AI-driven insights that help track opportunities efficiently by analyzing market behavior and technical patterns across thousands of stocks and ETFs.

Final Assessment

Reaching $250 would require COKE to first reclaim its all-time high near $220 and then extend higher, a move of roughly 30% from recent levels. The bullish foundation — strong pricing power, a diversified brand portfolio, and aggressive buybacks — gives the target genuine credibility. However, margin pressure, a leveraged balance sheet, and softening net income suggest the move is unlikely to be swift or linear. Investors should monitor earnings momentum, buyback activity, and whether the stock can hold above its prior record high before a sustained advance toward $250 becomes realistic. I’m watching this closely for any signs of renewed momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: COKE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


COKE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for COKE turned positive on August 24, 2026. Looking at past instances where COKE's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 24, 2026. You may want to consider a long position or call options on COKE as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

COKE moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COKE crossed bullishly above the 50-day moving average on July 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COKE advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 306 cases where COKE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COKE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COKE broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COKE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.123) is normal, around the industry mean (6.143). P/E Ratio (25.578) is within average values for comparable stocks, (47.855). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.764). COKE has a moderately low Dividend Yield (0.005) as compared to the industry average of (0.025). P/S Ratio (1.841) is also within normal values, averaging (3.023).

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), PepsiCo (NASDAQ:PEP).

Industry description

Non-alcoholic drinks include traces of alcohol or low alcohol content or without alcohol or alcohol removed. Functional Beverages, Carbonated Soft Drinks (CSDs), Sports Drinks, Fruit Beverages, and Bottled Water are some common types of non-alcoholic beverages. The largest segment in this market is soft drinks (think Pepsi and Coke). Many established companies in this space have also been stepping up production of low to zero-calorie varieties in recent years, to cater to a rising number of health-conscious consumers. Coca-Cola Company, Pepsico Inc, Keurig Dr Pepper Inc. and Monster Beverage Corporation are some major non-alcoholic beverage makers.

Market Cap

The average market capitalization across the Beverages: Non-Alcoholic Industry is 49.55B. The market cap for tickers in the group ranges from 1.77K to 395.79B. KO holds the highest valuation in this group at 395.79B. The lowest valued company is BVNNF at 1.77K.

High and low price notable news

The average weekly price growth across all stocks in the Beverages: Non-Alcoholic Industry was 7%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was -9%. SUJA experienced the highest price growth at 36%, while PRMB experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Beverages: Non-Alcoholic Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 5% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 59
Price Growth Rating: 58
SMR Rating: 61
Profit Risk Rating: 73
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
COKE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of non-alcoholic beverages

Industry BeveragesNonAlcoholic

Profile
Details
Industry
Beverages Non Alcoholic
Address
4100 Coca-Cola Plaza
Phone
+1 980 392-8298
Employees
17000
Web
https://www.cokeconsolidated.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.